
Marshall Wace
Europe, England, United Kingdom, London'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
Description
Marshall Wace is a global asset manager that offers a diverse range of investors alternative investment solutions.
Investor Profile
Marshall Wace has made 61 investments, with 12 in the past 12 months and 26% as lead.
Stage Focus
- Series B (21%)
- Series C (21%)
- Post Ipo Equity (16%)
- Series E (11%)
- Series Unknown (8%)
- Series D (7%)
- Series A (5%)
- Private Equity (5%)
- Series F (3%)
- Seed (2%)
Country Focus
- United States (77%)
- India (8%)
- Switzerland (5%)
- United Kingdom (3%)
- Canada (3%)
- Singapore (2%)
- Israel (2%)
Industry Focus
- Biotechnology
- Health Care
- Financial Services
- Fintech
- Pharmaceutical
- Therapeutics
- Medical
- Life Science
- Blockchain
- Cryptocurrency
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.